We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Forrester Research
FORR
$224M
| $982K | ﹤0.01% |
33,746
+142
| +0.4% | +$4.22K |
|
|
VMEO
2277
DELISTED
Vimeo
VMEO
| $980K | ﹤0.01% |
237,848
+36,161
| +18% | +$137K |
|
2278
Bladex Inc
BLX
$2.14B
| $980K | ﹤0.01% |
44,409
+2,200
| +5% | +$42.2K |
|
2279
UBS Group
UBS
$176B
| $978K | ﹤0.01% |
+48,233
| New | +$970K |
|
|
EB
2280
DELISTED
Eventbrite
EB
| $977K | ﹤0.01% |
102,312
-1,675
| -2% | -$13.2K |
|
|
XRN
2281
Chiron Real Estate Inc
XRN
$477M
| $977K | ﹤0.01% |
21,399
-207
| -1% | -$9.35K |
|
2282
ACM Research
ACMR
$5.79B
| $975K | ﹤0.01% |
74,536
-285
| -0.4% | -$3K |
|
2283
Health Catalyst
HCAT
$128M
| $975K | ﹤0.01% |
77,991
-9,618
| -11% | -$115K |
|
2284
Smith & Wesson
SWBI
$637M
| $972K | ﹤0.01% |
74,523
-3,231
| -4% | -$39.4K |
|
|
EU
2285
enCore Energy
EU
$243M
| $969K | ﹤0.01% |
+402,052
| New | +$898K |
|
2286
Editas Medicine
EDIT
$442M
| $963K | ﹤0.01% |
117,059
+5,642
| +5% | +$49.2K |
|
2287
CRA International
CRAI
$1.06B
| $963K | ﹤0.01% |
9,441
-733
| -7% | -$73.8K |
|
2288
Evolv Technologies
EVLV
$1.1B
| $962K | ﹤0.01% |
160,319
+32,324
| +25% | +$153K |
|
2289
KT
KT
$8.81B
| $961K | ﹤0.01% |
+85,045
| New | +$991K |
|
2290
SmartRent
SMRT
$272M
| $960K | ﹤0.01% |
250,524
+98,131
| +64% | +$300K |
|
2291
Genco Shipping & Trading
GNK
$1.1B
| $959K | ﹤0.01% |
68,386
+10,449
| +18% | +$150K |
|
|
FRG
2292
DELISTED
Franchise Group, Inc.
FRG
| $959K | ﹤0.01% |
33,484
-2,906
| -8% | -$83.3K |
|
2293
Mitek Systems
MITK
$834M
| $958K | ﹤0.01% |
88,419
+31,790
| +56% | +$311K |
|
2294
Amplitude
AMPL
$1.41B
| $958K | ﹤0.01% |
87,072
+14,360
| +20% | +$155K |
|
|
OLO
2295
DELISTED
Olo Inc
OLO
| $954K | ﹤0.01% |
147,676
+6,216
| +4% | +$44.7K |
|
|
AMK
2296
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $954K | ﹤0.01% |
32,161
-2,486
| -7% | -$73K |
|
2297
ORIX
IX
$43.5B
| $951K | ﹤0.01% |
+52,125
| New | +$903K |
|
2298
SkinHealth Systems
SKIN
$85.7M
| $951K | ﹤0.01% |
113,567
-4,261
| -4% | -$44.3K |
|
|
EVA
2299
DELISTED
Enviva Inc.
EVA
| $948K | ﹤0.01% |
87,377
+33,607
| +63% | +$489K |
|
2300
Coherus Oncology
CHRS
$196M
| $944K | ﹤0.01% |
221,087
+15,314
| +7% | +$90.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.